Edge Article
Chemical Science
Rt ¼ 7.06 min (major enantiomer, 48) and Rt ¼ 11.73 min (minor
enantiomer, ent-48). Rf ¼ 0.25 (hexane : CH2Cl2 : ethyl acetate
8 : 8 : 1). Spectral data for 48: 1H NMR (500 MHz, CDCl3) d0.80
(t, 3H, J ¼ 7.2 Hz), 1.04–1.16 (m, 1H), 1.24–1.36 (m, 1H), 1.42–
1.50 (m, 1H), 1.68–1.76 (m, 1H), 2.241 (s, 6H), 2.242 (s, 6H),
3.63–3.68 (m, 1H), 3.70 (s, 3H), 3.71 (s, 3H), 4.83 (d, J ¼ 5.5 Hz,
1H), 5.70 (s, 1H), 6.82 (s, 2H), 6.85 (s, 2H); 13C NMR (150 MHz,
CDCl3) d 13.65, 16.19, 16.20, 18.90, 31.43, 57.39, 59.01, 59.62,
59.63, 60.19, 128.13, 128.95, 130.84, 131.06, 132.92, 133.82,
156.44, 156.60, 163.99; IR (thin lm) 2934(w), 1767(s), 1485(w),
1221(w) cmꢀ1; HRMS calcd for C25H33NO3Cl (M + H, ESI+) m/z
Experimental section
Multi-component catalytic asymmetric aziridination of
butanal
To a 25 mL ame-dried Schlenck ask equipped with a stir bar
and lled with N2 was added (S)-VAPOL (13.7 mg, 0.025 mmol),
B(OPh)3 (21.8 mg, 0.075 mmol) and amine 79 (149.7 mg, 0.5
mmol). Dry toluene (1 mL) was added under an N2 atmosphere
to dissolve the reagents. The reaction mixture was stirred at
˚
room temperature for 1 h. Then 4 A molecular sieves (150 mg,
freshly ame-dried) were added. Aer the reaction mixture was
cooled to ꢀ10 ꢁC, butanal 80 (47.0 mL, 0.522 mmol, 1.04 equiv.)
was added followed by the addition of ethyl diazoacetate (EDA)
81 (125 mL, 1.00 mmol, 2.00 equiv.). The resulting mixture was
stirred for 24 h at ꢀ10 ꢁC. The reaction was diluted by addition
of hexane (6 mL). The reaction mixture was then ltered
through a Celite pad to a 100 mL round bottom ask. The
reaction ask was rinsed with EtOAc (3 mL ꢂ 3) and the rinse
was ltered through the same Celite pad. The resulting solution
was then concentrated in vacuo followed by exposure to high
vacuum (0.05 mm Hg) for 1 h to afford the crude aziridine 82 as
a viscous yellow oil.
20
430.2149, meas. 430.2141; [a]D ꢀ13.7ꢁ (c 1.0, CH2Cl2) on 96%
ee material.
Acknowledgements
This work was supported by the National Institute of General
Medical Sciences (GM 094478).
Notes and references
1 S. A. Testero, J. F. Fisher and S. Mobashery, b-Lactam
Antibiotics, in Burger’s Medicinal Chemistry, Drug Discovery
and Development, ed. D. J. Abraham and D. P. Rotella,
Wiley-VCH, Hoboken, NJ, 7th edn, 2010, vol. 7, pp. 259–404.
2 P. D. Mehta, N. P. S. Sengar and A. K. Pathak, Eur. J. Med.
Chem., 2010, 45, 5541–5560, and references therein.
3 (a) S. France, A. Weatherwax, A. E. Taggi and T. Lectka, Acc.
Chem. Res., 2004, 37, 592–600; (b) A. Fu and T. T. Tidwell,
Tetrahedron, 2008, 64, 10465–10496; (c) A. Brandi, S. Cicchi
and F. M. Cordero, Chem. Rev., 2008, 108, 3988–4035; (d)
D. H. Paull, A. Weatherwax and T. Lectka, Tetrahedron,
2009, 65, 6771–6803.
4 S. Calet, F. Urso and H. Alper, J. Am. Chem. Soc., 1989, 111,
931–934.
5 (a) X. Yang, V. D. Bumbu and V. B. Birman, Org. Lett., 2011,
13, 4755–4757; (b) V. D. Bumbu and V. B. Birman, J. Am.
Chem. Soc., 2011, 133, 13902–13905.
6 (a) M. P. Doyle and A. V. Kalinin, Synlett, 1995, 1075–1076; (b)
For a review, see: P. M. P. Gois and C. A. M. Afonso, Eur. J.
Org. Chem., 2004, 3773–3788.
7 (a) M. Miura, M. Enna, K. Okuro and M. Nomura, J. Org.
Chem., 1995, 60, 4999–5004; (b) M. M. C. Lo and G. C. Fu,
J. Am. Chem. Soc., 2002, 124, 4572–4573; (c) R. Pal,
S. C. Ghosh, K. Chandra and A. Basak, Synlett, 2007, 2321–
2330; (d) T. Saito, T. Kikuchi, H. Tanabe, J. Yahiro and
T. Otani, Tetrahedron Lett., 2009, 50, 4969–4972.
8 (a) H. Fujieda, M. Kanai, T. Kambara, A. Iida and
K. Tomioka, J. Am. Chem. Soc., 1997, 119, 2060–2061; (b)
T. Kambara and K. Tomioka, Chem. Pharm. Bull., 2000, 48,
1577–1580.
9 For representative examples, see: (a) A. E. Taggi, A. M. Hafez,
H. Wack, B. Young, W. J. Drury III and W. T. Lectka, J. Am.
Chem. Soc., 2000, 122, 7831–7832; (b) B. L. Hodous and
G. C. Fu, J. Am. Chem. Soc., 2002, 124, 1578–1579; (c)
E. C. Lee, B. L. Hodius, E. Bergin, C. Shih and G. C. Fu, J.
Am. Chem. Soc., 2005, 127, 11586–11587; (d) S. France,
Hydrolysis
To the solution of the crude aziridine 82 in ethanol (2 mL) was
added a solution of KOH (140.3 mg, 2.50 mmol, 5.00 equiv.) in
H2O (2 mL). The resulting mixture was reuxed for 1 h and then
cooled to rt. Then aq. citric acid (2 N, 2.5 mL) and ether (10 mL)
were added. The organic layer was separated and the aqueous
layer was extracted with ether (3 ꢂ 10 mL). The combined
organic extracts were dried (Na2SO4) and ltered. The ltrate
was concentrated to afford the crude aziridine acid as a yellow
foamy solid.
Ring-expansion
To a ame-dried round bottom ask equipped with a stir bar
and lled with N2 was added dry DMF (147.5 mL, 1.9 mmol, 3.8
equiv.) and dry CH2Cl2 (1 mL). The ask was tted with a rubber
septum and a nitrogen balloon. Then (COCl)2 (131 mL, 1.53
mmol, 3.06 equiv.) was added dropwise to the reaction ask
with stirring and the Vilsmeier salt precipitated out as a white
solid. The mixture was stirred for 20 min at room temperature
and cooled to 0 ꢁC. A solution of the crude aziridine acid in dry
CH2Cl2 (5 mL) was added dropwise to the reaction ask con-
taining the Vilsmeier salt (1.53 mmol, 3.06 equiv.) over 5 min.
The reaction mixture was stirred for 10 min at 0 ꢁC and
concentrated to afford a foamy crude product. The yield of
lactam 48 was 59% (over three steps) as determined from the 1H
NMR spectrum of the crude reaction mixture in CDCl3 with the
aid of Ph3CH as an internal standard. The product was puried
by column chromatography (silica gel, 25 ꢂ 210 mm, hex-
ane : CH2Cl2 : ethyl acetate 8 : 8 : 1) to afford b-lactam 48 (124
mg, 0.29 mmol) as a colorless semi-solid in 58% isolated yield
(over three steps); The optical purity was determined to be 96%
ee by HPLC analysis (Chiralcel OD-H column, 98 : 2 hexane–2-
propanol at 222 nm, ow-rate 1.0 mL minꢀ1); retention times:
This journal is ª The Royal Society of Chemistry 2013
Chem. Sci., 2013, 4, 622–628 | 627